Sun Pharma profit halves in Q4, US Biz Jumps by 20%
  • WebDesk BTVI
  • May 29 2019

Although profits halved in the quarter for Sun Pharma, brokerages have remained positive on the stock. Amey Chalke of HDFC Securities talks about growth expectations and future of its India business.